Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
Taiwan · Delayed Price · Currency is TWD 35.45
+0.50 (1.43%)
Apr 17, 2026, 2:00 PM CST
Genomics BioSci & Tech. Revenue
In the year 2025, Genomics BioSci & Tech. had annual revenue of 708.38M TWD with 46.74% growth. Genomics BioSci & Tech. had revenue of 220.06M in the quarter ending December 31, 2025, with 42.53% growth.
Revenue
708.38M
Revenue Growth
+36.86%
P/S Ratio
3.66
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 708.38M | 225.62M | 46.74% |
| Dec 31, 2024 | 482.75M | 86.61M | 21.86% |
| Dec 31, 2023 | 396.14M | -22.86M | -5.46% |
| Dec 31, 2022 | 419.00M | 29.04M | 7.45% |
| Dec 31, 2021 | 389.97M | -53.21M | -12.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.14B |
| Apex Biotechnology | 1.94B |
| Chunghwa Chemical Synthesis & Biotech | 804.88M |
| G&E Herbal Biotechnology | 309.13M |
| HeXun Biosciences | 293.23M |
| 3D Global Biotech | 206.74M |
| Intech Biopharm | 107.53M |
| GlycoNex Incorporation | 37.86M |